Drawing for RIPLE

USPTO serial 99348375

RIPLE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
ELLINGER FATHY, JESSICA M
Law office
TMO LAW OFFICE 110

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with RIPLE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Dustin Luettgen

Dustin Luettgen SonoThera, Inc.201 Haskins Way5th FloorSouth San Francisco, CA 94080

Goods and services

ClassDescriptionStatusFirst use
005Gene therapy preparations, namely, biological preparations for the treatment of human diseases or disorders, namely, diseases of genetic or genetic predisposition etiology; kits comprised of gene therapies, namely, biological preparations and pharmaceutical preparations both for the treatment of human diseases and disorders, namely, diseases of genetic or genetic predisposition etiology; gene delivery platform, namely, biological delivery agents for the treatment of human diseases and disorders, namely, diseases of genetic or genetic predisposition etiologyACTIVE—
009Software for operation of ultrasound systems and ultrasound probes for administration of pharmaceutical agents, namely, biological preparations for the treatment of human diseases or disorders and gene therapy preparations.ACTIVE—
010Ultrasound systems and ultrasound probes for administration of pharmaceutical agents, namely, biological preparations for the treatment of human diseases or disorders and gene therapy preparations.ACTIVE—
042Software as a service for the operation of ultrasound systems and ultrasound probes for administration of pharmaceutical agents, namely, biological preparations for the treatment of human diseases or disorders and gene therapy preparations.; Research and development in the field of gene therapyACTIVE—
044Medical services for ultrasound mediated administration of pharmaceutical agents, namely, biological preparations for the treatment of human diseases or disorders and gene therapy preparations.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Aug 30, 2026MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 30, 2026ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 17, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Apr 17, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Jan 20, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 20, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 20, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 9, 2026DOCKASSIGNED TO EXAMINER—
Jan 8, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 20, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 20, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance